Connect Biopharma Holdings Ltd Financial Flexibility Index
Connect Biopharma Holdings Ltd financial flexibility index. Connect Biopharma Holdings Ltd (CNTB) has a Financial Flexibility Index of -1.92x as of June 2026. Free cash flow of $-31.91 Million (operating CF $-31.93 Million minus capex $16.00K) represents -2% of total liabilities ($16.61 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Connect Biopharma Holdings Ltd (2018–2025)
Financial flexibility index of Connect Biopharma Holdings Ltd from 2018 to 2025. Historical Financial Flexibility Index trend for Connect Biopharma Holdings Ltd across 8 annual periods. Check CNTB cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Connect Biopharma Holdings Ltd Financial Flexibility Index by Year (2018–2025)
Connect Biopharma Holdings Ltd financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Connect Biopharma Holdings Ltd. For the full cash flow conversion analysis, see Connect Biopharma Holdings Ltd cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.60x | $-50.77 Million | $-51.21 Million | $14.10 Million | ▼ -43.7% |
| 2024 | -2.51x | $-22.86 Million | $-23.61 Million | $9.12 Million | ▼ -36.2% |
| 2023 | -1.84x | $-47.64 Million | $-47.93 Million | $25.88 Million | ▲ +68.0% |
| 2022 | -5.75x | $-94.99 Million | $-99.27 Million | $16.52 Million | ▲ +78.3% |
| 2021 | -26.46x | $-497.40 Million | $-544.93 Million | $18.80 Million | ▼ -5527.8% |
| 2020 | -0.47x | $-23.26 Million | $-25.61 Million | $49.47 Million | ▲ +49.4% |
| 2019 | -0.93x | $-12.94 Million | $-13.09 Million | $13.91 Million | ▼ -21.6% |
| 2018 | -0.76x | $-67.84 Million | $-69.03 Million | $88.70 Million | — |